Search

Search Results

Found 59 items.

Widespread high grade prostatic intraepithelial neoplasia on biopsy predicts the risk of prostate cancer: A 12 months analysis after three consecutive prostate biopsies

Cosimo De Nunzio, Simone Albisinni, Antonio Cicione, Mauro Gacci, Costantino Leonardo, Francesco Esperto, Andrea Tubaro

59-64

2013-06-24

Published: June 24, 2013

1939

PDF: 1514
MRI/US fusion prostate biopsy: Our initial experience

Vito Lacetera, Bernardo Cervelli, Antonio Cicetti, Giuliana Gabrielloni, Michele Montesi, Roberto Morcellini, Gianni Parri, Emilio Recanatini, Gianluca Giglioni, Andrea Benedetto Galosi, Valerio Beatrici

296-299

2016-12-30

Published: December 30, 2016

2846

PDF: 1311
Chronic inflammation of the prostate type IV with respect to risk of prostate cancer

Antonio B. Porcaro, Emanuele Rubilotta, Aldo Petrozziello, Claudio Ghimenton, Filippo Migliorini, Stefano Zecchini Antoniolli, Vincenzo Lacola, Carmelo Monaco, Pierpaolo Curti, Stefano Cavalleri, Romeo Pianon, Walter Artibani

208-211

2014-09-30

Published: September 30, 2014

2556

PDF: 1045

SUPPLEMENTARY MATERIAL: 363
Relevance of prostate cancer in patients with synchronous invasive bladder urothelial carcinoma: a monocentric retrospective analysis

Lucio Dell’Atti

76-79

2015-03-31

Published: March 31, 2015

1576

PDF: 910
Accuracy of 3 Tesla pelvic phased-array multiparametric MRI in diagnosing prostate cancer at repeat biopsy

Pietro Pepe, Antonio Garufi, Giandomenico Priolo, Giuseppe Dibenedetto, Michele Salemi, Michele Pennisi, Filippo Fraggetta, Francesco Aragona, Michele Barbera

336-339

2014-12-30

Published: December 30, 2014

2295

PDF: 1540
Potential usefulness of CTC detection in follow up of prostate cancer patients. A preliminary report obtained by using Adnagene platform

Giuseppe Albino, Francesca Vendittelli, Carmela Paolillo, Cecilia Zuppi, Ettore Capoluongo

164-169

2013-12-31

Published: December 31, 2013

2142

PDF: 2022
Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy

Pietro Pepe, Sebastiano Cimino, Antonio Garufi, Giandomenico Priolo, Giorgio Ivan Russo, Raimondo Giardina, Giulio Reale, Michele Barbera, Paolo Panella, Michele Pennisi, Giuseppe Morgia

300-303

2016-12-30

Published: December 30, 2016

2325

PDF: 1225
Association of metabolic syndrome with prostate cancer diagnosis and aggressiveness in patients undergoing transrectal prostate biopsy

Charalampos Fragkoulis, Ioannis Glykas, Lazaros Tzelves, Konstantinos Stasinopoulos, Lazaros Lazarou, Andreas Kaoukis, Athanasios Dellis, Georgios Stathouros, Georgios Papadopoulos, Konstantinos Ntoumas

291-295

2021-09-30

Published: September 30, 2021

797

PDF: 468
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy

Antonio B. Porcaro, Beatrice Caruso, Alessandro Terrin, Nicolò De Luyk, Giovanni Cacciamani, Paolo Corsi, Davide Inverardi, Davide De Marchi, Roberto Baldassarre, Mariangela Cerruto, Claudio Ghimenton, Matteo Brunelli, Stefano Zecchini Antoniolli, Aldo Petrozziello, Walter Artibani

17-22

2016-03-31

Published: March 31, 2016

2017

PDF: 841

SUPPLEMENTARY MATERIAL: 322
Clinical effects and economical impact of dutasteride and finasteride therapy in Italian men with LUTS

Luca Cindolo, Francesco Berardinelli, Caterina Fanizza, Marilena Romero, Luisella Pirozzi, Fabiola Raffaella Tamburro, Fabrizio Pellegrini, Fabio Neri, Andrea Pitrelli, Luigi Schips

200-206

2013-12-31

Published: December 31, 2013

2922

PDF: 2159
Does prolonged anti-inflammatory therapy reduce number of unnecessary repeat saturation prostate biopsy?

Giuseppe Candiano, Pietro Pepe, Francesco Pietropaolo, Francesco Aragona

65-68

2013-06-24

Published: June 24, 2013

1767

PDF: 1691
In the search of novel urine biomarkers for the early diagnosis of prostate cancer. Intracellular or secreted proteins as the target group? Where and how to search for possible biomarkers useful in the everyday clinical practice

Amalia Katafigioti, Ioannis Katafigiotis, Stavros Sfoungaristos, Christos Alamanis, Konstantinos Stravodimos, Ioannis Anastasiou, Eleni Roumelioti, Mordechai Duvdevani, Constantinos Constantinides

195-200

2016-10-05

Published: October 5, 2016

2659

PDF: 1300
Diabetes mellitus and prostate cancer metabolism: Is there a relationship?

Hugo Pontes Antunes, Ricardo Teixo, João André Carvalho, Miguel Eliseu, Inês Marques, Ana Mamede, Rita Neves, Rui Oliveira, Edgar Tavares-da-Silva, Belmiro Parada, Ana Margarida Abrantes, Arnaldo Figueiredo, Maria Filomena Botelho

184-190

2018-09-30

Published: September 30, 2018

2169

PDF: 862
Association between large prostate calculi and prostate cancer

Cem Yucel, Salih Budak

181-183

2018-09-30

Published: September 30, 2018

1312

PDF: 548
Effect of green tea catechins in patients with high-grade prostatic intraepithelial neoplasia: Results of a short-term double-blind placebo controlled phase II clinical trial

Salvatore Micali, Angelo Territo, Giacomo Maria Pirola, Nancy Ferrari, Maria Chiara Sighinolfi, Eugenio Martorana, Michele Navarra, Giampaolo Bianchi

197-202

2017-10-03

Published: October 3, 2017

2654

PDF: 1416
Accuracy of pelvic multiparametric MRI in diagnosing local recurrence following radical prostatectomy. Case report and revision of the literature

Pietro Pepe, Antonio Garufi, Giandomenico Priolo, Michele Pennisi

335-336

2016-01-14

Published: January 14, 2016

1856

PDF: 764
Results of tadalafil treatment in patients following an open nerve-sparing radical prostatectomy

Erkan Hirik, Aliseydi Bozkurt, Mehmet Karabakan, Özkan Onuk, Mustafa Bahadır Can Balcı, Memduh Aydın, Murat Çakan, Barıs Nuhoglu

4-6

2016-03-31

Published: March 31, 2016

2753

PDF: 1442
Prognostic value of subclassification (pT2 stage) of pathologically organ-confined prostate cancer: Confirmation of the changes introduced in the 8th edition of the American Joint Committee on Cancer (AJCC) staging system

Hugo Pontes Antunes, Belmiro Parada, João Carvalho, Miguel Eliseu, Roberto Jarimba, Rui Oliveira, Edgar Tavares-da-Silva, Arnaldo Figueiredo

191-194

2018-09-30

Published: September 30, 2018

998

PDF: 575
Solitary prostatic cancer metastasis to the testis: A case report and lessons to learn

Asmaa Ismail, Hazem Elmansy, Walid Shahrour, Owen Prowse, Ahmed Kotb

265-266

2020-01-14

Published: January 14, 2020

1082

PDF: 587
Ductal prostate cancer staging: Role of PSMA PET/CT

Pietro Pepe, Ludovica Pepe, Mara Curduman, Michele Pennisi, Filippo Fraggetta

2024-02-16

Published: February 16, 2024

632

PDF: 360
Do all patients with suspicious prostate cancer need Multiparametric Magnetic Resonance Imaging before prostate biopsy?

Sara Teixeira Anacleto, Joana Neves Alberto, Emanuel Carvalho Dias, Pedro Sousa Passos, Mário Cerqueira Alves

32-36

2022-03-28

Published: March 28, 2022

636

PDF: 391
Medical management in locally advanced and metastatic prostate cancer: Does changes in treatment policy have any specific effect on PSA levels?

Murat Bagcioglu, Cristian Surcel, Serkan Ozcan, Cristian Mirvald, Mehmet Ali Karagoz, Mert Ali Karadag, Emre Huri, Kemal Sarica

282-286

2017-12-31

Published: December 31, 2017

1083

PDF: 571
Lymphocyte-to-monocyte ratio is a valuable marker to predict prostate cancer in patients with prostate specific antigen between 4 and 10 ng/dl

Volkan Caglayan, Efe Onen, Sinan Avci, Murat Sambel, Metin Kilic, Sedat Oner, Mustafa Murat Aydos, Halil Emre Yıldız

270-275

2019-01-17

Published: January 17, 2019

2344

PDF: 1372
Assesment of anogenital distance as a marker in diagnosis of prostate cancer

Aytac Sahin, Musab Ali Kutluhan, Tuncay Toprak, Yasin Vural, Ahmet Ürkmez, Serkan Akan, Ayhan Verit

2019-10-02

Published: October 2, 2019

1774

PDF: 717
Comparison between “In-bore” MRI guided prostate biopsy and standard ultrasound guided biopsy in the patient with suspicious prostate cancer: Preliminary results

Daniele D’Agostino, Federico Mineo Bianchi, Daniele Romagnoli, Paolo Corsi, Marco Giampaoli, Riccardo Schiavina, Eugenio Brunocilla, Walter Artibani, Angelo Porreca

2019-07-02

Published: July 2, 2019

1676

PDF: 688
Multiparametric MRI targeted prostate biopsy: When omit systematic biopsy?

Pietro Pepe, Ludovica Pepe, Vincenzo Fiorentino, Mara Curduman, Filippo Fraggetta

2024-11-11

Published: November 11, 2024

24

PDF: 10
The presence of chronic inflammation in positive prostate biopsy is associated with upgrading in radical prostatectomy

Ekrem Guner, Yavuz Onur Danacioglu, Yusuf Arikan, Kamil Gokhan Seker, Salih Polat, Halil Firat Baytekin, Abdulmuttalip Simsek

280-284

2021-09-30

Published: September 30, 2021

1015

PDF: 477
A single-operator experience using EchoLaser SoracteLite^TM for focal laser ablation of prostate cancer: one more arrow in the quiver for the conservative management of the disease

Iacopo Meneghetti, Demostene Giardino, Riccardo Morganti, Vincenzo Marino, Filippo Menchini Fabris, Riccardo Bartoletti, Novello Pinzi

406-412

2022-12-27

Published: December 27, 2022

827

PDF: 403
Lesion location agreement between prostatic multiparametric magnetic resonance, cognitive fusion biopsy and radical prostatectomy piece

Mario Lourenço, Pedro Pissarra, Duarte Vieira e Brito, Miguel Eliseu, Joao Pedro Peralta, Arnaldo Figueiredo, Cristina Marques

218-223

2020-01-13

Published: January 13, 2020

897

PDF: 405
Expression of miR-132 and miR-212 in prostate cancer and metastatic lymph node: Case report and revision of the literature

Michele Salemi, Angela Pettinato, Filippo Fraggetta, Aldo E. Calogero, Michele Pennisi, Ludovica Pepe, Pietro Pepe

2020-10-01

Published: October 1, 2020

1076

PDF: 603
The sufficiency of 6 core sextant prostate biopsy in patients with prostate specific antigen (PSA) values over 20 ng/mL

Cem Yücel, Salih Budak, Erdem Kısa, Orcun Celik, Zafer Kozacıoglu

104-106

2018-06-30

Published: June 30, 2018

1442

PDF: 513
Influence of sociodemographic factors on treatment’s choice for localized prostate cancer in Portugal

Mário Pereira-Lourenço, Duarte Vieira e Brito, João Pedro Peralta, Ricardo Godinho, Paulo Conceiçao, Mário Reis, Carlos Rabaça, Amílcar Sismeiro

45-49

2020-04-06

Published: April 6, 2020

1004

PDF: 583
Attitudes and perceptions towards multiparametric magnetic resonance imaging of the prostate: A national survey among Italian urologists

Arnaldo Stanzione, Massimiliano Creta, Massimo Imbriaco, Roberto La Rocca, Marco Capece, Fabio Esposito, Ciro Imbimbo, Ferdinando Fusco, Giuseppe Celentano, Luigi Napolitano, Francesco Mangiapia, Vincenzo Mirone, Nicola Longo

2020-12-17

Published: December 17, 2020

907

PDF: 410
Clinical impact of ERG and PTEN status in prostate cancer patients underwent radical prostatectomy

Charalampos Fragkoulis, Ioannis Glykas, Lazaros Tzelves, Panagiotis Velissarios Stamatakos, Georgios Papadopoulos, Georgios Stathouros, Athanasios Dellis, Konstantinos Ntoumas, Akrivi Kostopoulou, Charalampos Deliveliotis, Athanasios Papatsoris

390-395

2022-12-27

Published: December 27, 2022

667

PDF: 348
The pathological and clinical features of anterior lesions of prostate cancer: Evaluation in a single cohort of patients

Daniele D'Agostino, Paolo Corsi, Michele Colicchia, Daniele Romagnoli, Gian Maria Busetto, Matteo Ferro, Alessandro Tafuri, Matteo Cevenini, Federico Mineo Bianchi, Marco Giampaoli, Angelo Porreca

2020-06-23

Published: June 23, 2020

1138

PDF: 658
Medium-term oncological outcomes of intermediate-risk prostate cancer treated with HIFU or cryotherapy. A single center 10-year experience

Nuno Dias, Lara Rodriguez-Sanchez, Gianmarco Colandrea, Petr Macek, Xavier Cathelineau

413-419

2022-12-27

Published: December 27, 2022

724

PDF: 418
Biopsy follow-up in patients with isolated atypical small acinar proliferation (ASAP) in prostate biopsy

Luca Leone, Vito Lacetera, Rodolfo Montironi, Ubaldo Cantoro, Alessandro Conti, Giulia Sbrollini, Luigi Quaresima, Luciana Mariani, Giovanni Muzzonigro, Andrea Benedetto Galosi

332-335

2014-12-30

Published: December 30, 2014

2629

PDF: 1341
Accuracy of PET-choline in nodal staging of localized very high-risk prostate cancer

Nuno Dias, Gianmarco Colandrea, Francisco Botelho, Lara Rodriguez-Sanchez, Yann Barbé, Petr Macek, Xavier Cathelineau

401-405

2022-12-27

Published: December 27, 2022

744

PDF: 490
Evaluation of the diagnostic and predictive power of PCA3 in the prostate cancer. A different best cut-off in each different scenario. Preliminary results

Giuseppe Albino, Ettore Capoluongo, Sandro Rocchetti, Sara Palumbo, Cecilia Zuppi, Ettore Cirillo-Marucco

306-310

2014-12-30

Published: December 30, 2014

1916

PDF: 1069
Is there a PSA cut-off value indicating incidental prostate cancer in patients undergoing surgery for benign prostatic hyperplasia?

Senol Tonyali, Cavit Ceylan, Erdogan Aglamis, Serkan Dogan, Sedat Tastemur, Mustafa Karaaslan

31-34

2021-03-18

Published: March 18, 2021

1237

PDF: 628
[68Ga]Ga-PSMA-11 PET-CT: Local preliminary experience in prostate cancer biochemical recurrence patients

João Carvalho, Pedro Nunes, Edgar Tavares da Silva, Rodolfo Silva, João Lima, Vasco Quaresma, Arnaldo Figueiredo

21-25

2021-03-18

Published: March 18, 2021

1168

PDF: 664
68Ga-PSMA PET/CT evaluation in men enrolled in prostate cancer Active Surveillance

Pietro Pepe, Ludovica Pepe, Marinella Tamburo, Giulia Marletta, Francesco Savoca, Michele Pennisi, Filippo Fraggetta

2023-05-22

Published: May 22, 2023

1054

PDF: 496
Prostatic fiducial markers implantation by transrectal ultrasound for adaptive image guided radiotherapy in localized cancer: 7-years experience

Vito Lacetera, Massimo Cardinali, Giovanna Mantello, Francesco Fenu, Giulia Sbrollini, Flavia Tombolini, Alessandro Conti, Stefania Maggi, Giovanni Muzzonigro, Andrea Benedetto Galosi

349-352

2014-12-30

Published: December 30, 2014

1991

PDF: 1177
Erectile dysfunction following hydrogel injection and hypofractionated radiotherapy for prostate cancer: Our experience in 56 cases

Pietro Pepe, Maria Tamburo, Paolo Panella, Ludovica Pepe, Giulia Marletta, Michele Pennisi, Francesco Marletta

166-168

2022-06-29

Published: June 29, 2022

1235

pdf: 570
Pulmonary recurrence from prostate cancer and biochemical remission after metastasis directed therapy. A case report

Riccardo Boschian, Michele Rizzo, Lorenzo Zandonà, Carlo Trombetta, Giovanni Liguori

74-75

2018-03-31

Published: March 31, 2018

1284

PDF: 560
Magnetic resonance imaging target fusion biopsy vs. transrectal ultrasound-guided biopsy - A comparative study of ISUP score upgrading risk in the ﬁnal radical prostatectomy specimen

Thiago Guimarães, Miguel Gil, Mariana Medeiros, Vanessa Andrade, João Guerra, Hugo Pinheiro, Francisco Fernandes, João Pina, João Lopes Dias, Luís Campos Pinheiro

278-284

2022-09-26

Published: September 26, 2022

1464

pdf: 557
Are elevated mitochondrial DNA fragments in prostatic inflammation a potential biomarker for prostate cancer?

Ugur Aferin, Nurten Bahtiyar, Ilhan Onaran, Hamdi Ozkara

2023-09-27

Published: September 27, 2023

599

PDF: 377
Targeted prostate biopsy: 68Ga-PSMA PET/CT vs. mpMRI in the diagnosis of prostate cancer

Pietro Pepe, Ludovica Pepe, Maria Tamburo, Giulia Marletta, Michele Pennisi, Filippo Fraggetta

274-277

2022-09-26

Published: September 26, 2022

2206

pdf: 955
Safety of transrectal ultrasound-guided prostate biopsy in patients affected by Crohn’s disease

Lucio Dell'Atti, Andrea Benedetto Galosi

106-109

2017-06-30

Published: June 30, 2017

1584

PDF: 865
Oncological and functional outcomes of extraperitoneal laparoscopic radical prostatectomy: An 18-years, single-center experience

Francesco Saverio Grossi, Emanuele Utano, Paolo Minafra, Pier Paolo Prontera, Francesco Schiralli, Antonio De Cillis, Evangelista Martinelli, Marco Lattarulo, Meri Luka, Antonio Carrieri, Angelo D’Elia

268-273

2021-09-30

Published: September 30, 2021

1104

PDF: 487

1 - 50 of 59 items 1 2 > >>

© PAGEPress 2008-2024 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy